[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Stakeholder](https://github.com/mm80843/T3.5/tree/pages/docs/Stakeholder/index.md) >> Individual ID:PBN__Stakeholder_34 

# __Manufacturers__

## Category to which it belongs

* [The industry of creating and supplying various devices, equipment, and platforms for different sectors and users.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_264.md)

## Closest similar item

* [Device manufacturer](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1953.md)
* [Device manufacturers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1431.md)
* [Manufacturer](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1882.md)
* [Manufacturing companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_735.md)
* [Manufacturing company](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_773.md)
* [Material manufacturers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1879.md)
* [Medical equipment manufacturers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1148.md)
* [Product owners](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2005.md)
* [Vehicle manufacturer](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1974.md)
* [Vehicle manufacturers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_546.md)

## Risk affecting this stakeholder

* [Accuracy, repeatability, and specificity challenges in detecting and preventing viruses using graphene-coated materials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1172.md)
* [Agglomeration problems with gbns](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_480.md)
* [Barriers to innovation due to regulatory procedures](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10.md)
* [Challenges in data sharing and supply chain complexity](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1392.md)
* [Challenges related to cost and processing of graphene-based coatings at different surfaces](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2101.md)
* [Compatibility issues with 6g devices and sensors](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1123.md)
* [Complexity and implementation issues of 5g devices, including power consumption and multi-band support](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1742.md)
* [Cost of components may be prohibitively high for large-scale production, reducing accessibility of the prototype](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1126.md)
* [Cost-effectiveness of additive manufacturing technologies using fff, up to a certain production volume, may lead to limited availability of ppe.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1128.md)
* [Creation of new types of devices leading to obsolescence of existing ones](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3968.md)
* [Cytotoxicity of graphene derivatives due to negatively charged groups](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3982.md)
* [Decline in industrial production and retail sales](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3987.md)
* [Dependence on new nanomaterials and disinfection systems with self-reactivation mechanisms may create a false sense of security and lead to inadequate disinfection.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3988.md)
* [Development of graphene oxide go incorporated cotton fabrics as antimicrobial materials may introduce new risks if the effectiveness of the material is not thoroughly validated.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_4009.md)
* [Discrepancies in reported biocidal mechanisms of cu 2 o compounds for viral inactivation](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_4101.md)
* [Disruption in the supply chain](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_4708.md)
* [Disruption of supply chains](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_4982.md)
* [Disruption of work and production due to pandemic and lockdown policies](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5006.md)
* [Disruptions to global and national supply chains](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5034.md)
* [Effectiveness of the anti-sars-cov-2 coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5035.md)
* [Ethical considerations in repurposing consumer devices for healthcare](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5038.md)
* [Exposure to foreign supply shocks for smaller economies](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5044.md)
* [Financial subsidies may lead to an increase in the production and distribution of iot devices, potentially increasing the risk of disease transmission through contaminated devices.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5045.md)
* [Fragility of global supply network exposed by covid-19 outbreaks](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5046.md)
* [Inadequate consideration of sustainability in the design and manufacturing of iot devices](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5053.md)
* [Inadequate fluid barrier and air filtration in non-fda-cleared 3d-printed ppe devices.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5054.md)
* [Inadequate redundancy in production lines or supply chains may lead to disruptions in crucial product availability during a contagious disease outbreak.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5482.md)
* [Inadequate understanding of paint nature and endurance](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5503.md)
* [Incomplete or insufficient inactivation of sars-cov-2 on graphene-based coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5504.md)
* [Increased sales and adoption of iot devices and smart home systems may result in environmental impacts from electronic waste and energy consumption.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5511.md)
* [Increased use of masks and mask production can contribute to environmental waste and pollution](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6069.md)
* [Ineffective regulation of supply chains and global corporations](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6129.md)
* [Lack of complete assessment of cytotoxicity for antiviral materials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6249.md)
* [Lack of legal and financial support from authorities](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6284.md)
* [Lack of promotion of green logistics and waste management regulations](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6285.md)
* [Lack of standardized testing for uvgi effectiveness](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6813.md)
* [Lack of standardized tests and protocols for uvgi efficacy and testing](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6872.md)
* [Lack of understanding of the effectiveness of cloth-based face masks in reducing the emission of particles](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7148.md)
* [Legal issues arising from the complex environment of 5g-enabled smart devices for e-health.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_8193.md)
* [Manufacturing cost and process may limit scalability and affordability of the monitoring system.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_9965.md)
* [Misuse of antimicrobial particles in paints](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_9980.md)
* [Neglect of closed-loop supply chains and circular economy models in certain sectors](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10009.md)
* [Participants were not willing to pay for certain hems features, potentially impacting the adoption and implementation of these features.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10021.md)
* [Poor solubility and processing of graphene materials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10076.md)
* [Potential contamination of graphene-based products with sars-cov-2 during manufacturing or handling](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10080.md)
* [Potential failure of other coating technologies amine and ammonium-based polymers to inactivate the virus](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10082.md)
* [Potential hazards posed by fff technology in ppe manufacturing, including lack of head protection, fitting problems, weight problems, reduced disinfection possibility, and other disadvantages.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10297.md)
* [Potential transmission of contagious diseases due to increased collaboration and reliance on diversified suppliers and manufacturers.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10435.md)
* [Rapid production and adoption of new mask technologies may lead to quality and safety issues](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10436.md)
* [Rigid international supply chains](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10437.md)
* [Risk of ineffective anti-sars-cov-2 coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11373.md)
* [Risks associated with the use of copper as a virus-inactivating solution](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11413.md)
* [Scalability and cost of graphene-based coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11414.md)
* [Shocks to other industries including ce-sensitive materials extraction and mining](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12431.md)
* [Shortages of health equipment and critical components](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12990.md)
* [Supply chain disruption](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13639.md)
* [Supply chain disruptions](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14157.md)
* [Temporary and potentially harmful nature of existing cleaning and disinfectant solutions](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14162.md)
* [Uncertain virucidal activity against specific viruses, such as sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17223.md)
* [Unprecedented energy consumption and high cost of energy-efficient devices](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17227.md)
* [Use of an unvalidated test method](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17613.md)
* [Use of low-cost open-source hardware and software may result in lower quality and reliability of monitoring systems.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17614.md)
* [Varied efficacy of copper surfaces based on copper content and form native, nanoparticle raises concerns about the uniformity of antiviral properties across different copper materials.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17883.md)
* [Varying filtering power of disposable surgical masks depending on the model and size of aerosol particles](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17936.md)
* [Vulnerability of global supply chains to disease-related disruptions](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18062.md)

## Risks that can be mitigated by this stakeholder

* [Accuracy, repeatability, and specificity challenges in detecting and preventing viruses using graphene-coated materials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1171.md)
* [Antimicrobial face mask becoming a potential source of viral transmission if not handled properly](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1172.md)
* [Bio composite materials as an alternative to reduce indoor air pollutants](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10.md)
* [Challenges in ventilator production](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2054.md)
* [Challenges related to cost and processing of graphene-based coatings at different surfaces](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1957.md)
* [Contagious diseases spread through skin contact with sensors or wearables](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1392.md)
* [Cost-effectiveness of additive manufacturing technologies using fff, up to a certain production volume, may lead to limited availability of ppe.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_901.md)
* [Creation of new types of devices leading to obsolescence of existing ones](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1123.md)
* [Delay in transmission synchronization](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1742.md)
* [Dependence on imports for vital equipment](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1485.md)
* [Disruption of supply chains](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2368.md)
* [Disruption of supply chains in the manufacturing industry due to workplace closures and reduced production](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2100.md)
* [Disruptions in industrial manufacturing and drop in commodity prices](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1125.md)
* [Ethical considerations in repurposing consumer devices for healthcare](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1357.md)
* [Failure to provide adequate protective equipment for healthcare workers](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1174.md)
* [Fluctuating demands for medical equipment](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2371.md)
* [Global supply chain vulnerabilities](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2373.md)
* [Hazardous waste from filter disposal](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1173.md)
* [Importing materials from different locations increases the risk of introducing foreign pathogens and contaminants into the manufacturing process.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2372.md)
* [Improper dispersion of nanomaterials like graphene and mnps may lead to reduced antimicrobial activity, allowing pathogens to spread](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2377.md)
* [Improper disposal of the biosensor patches may lead to potential disease spread.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2369.md)
* [Inadequate fluid barrier and air filtration in non-fda-cleared 3d-printed ppe devices.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1356.md)
* [Inadequate mixing of room air](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2376.md)
* [Inadequate protection of eyes from exposure to sars-cov-2 due to lack of safety goggles and visors](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1128.md)
* [Inadequate testing volume](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1127.md)
* [Incomplete or insufficient inactivation of sars-cov-2 on graphene-based coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3968.md)
* [Inconvenience and cost of mask filters in smart face masks](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_4118.md)
* [Inconvenience and noise of purifying shield](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5011.md)
* [Incorrect adhesion of facial filter leading to improper protection from sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5017.md)
* [Increase in disposable medical hardware and plastic packaging](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5018.md)
* [Increased use of face masks as a result of air quality concerns and the covid-19 pandemic.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5019.md)
* [Increased use of masks and mask production can contribute to environmental waste and pollution](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5024.md)
* [Increasing use of face masks and sanitizers may lead to environmental pollution and waste management issues.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5034.md)
* [Indoor air pollution from building materials and products](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5035.md)
* [Ineffective antiviral composites](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5043.md)
* [Inefficient negative air ionization](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5044.md)
* [Internationalisation of power supply may introduce compatibility issues and safety risks.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5045.md)
* [Lack of airtightness and safety concerns with reusable face shields](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5176.md)
* [Lack of clinical effectiveness measurement for face masks](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5481.md)
* [Lack of effective disinfectants](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6057.md)
* [Lack of interoperability](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6059.md)
* [Lack of personal protective equipment](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6069.md)
* [Lack of protective equipment](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6249.md)
* [Lack of regulation and standardization for uvgi installation techniques](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6284.md)
* [Lack of standardized tests and protocols for uvgi efficacy and testing](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6637.md)
* [Limited access to personal protective equipment ppe](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6639.md)
* [Limited production capacity of ppe facemasks](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6767.md)
* [Limited understanding of the long-term effectiveness of graphene-based surface coatings against sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6768.md)
* [Manufacturing cost and process may limit scalability and affordability of the monitoring system.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6769.md)
* [Noise and inconvenience of personal air-purifying shields](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6915.md)
* [Noise and size concerns with personal air-purifying shields](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6928.md)
* [Plug-and-play installation may lead to overlooking safety and environmental factors.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6929.md)
* [Poor contact with skin leading to compromised sensor accuracy](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6930.md)
* [Potential contamination of graphene-based products with sars-cov-2 during manufacturing or handling](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7153.md)
* [Potential hazards posed by fff technology in ppe manufacturing, including lack of head protection, fitting problems, weight problems, reduced disinfection possibility, and other disadvantages.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7154.md)
* [Potential inaccuracies in early detection of covid-19 using wearable technology.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7155.md)
* [Potential spread of contagious diseases through wearable technology](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_8912.md)
* [Potential toxicity of graphene-based nano materials when used in antiviral applications](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_9979.md)
* [Privacy and security risks with wearable technology data](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10017.md)
* [Production and distribution of face masks during a contagious disease outbreak](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10089.md)
* [Promotion of reusable masks may lead to improper maintenance and cleaning, increasing the risk of disease transmission](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10423.md)
* [Rapid increase in demand for testing kits](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10427.md)
* [Rapid manufacturing of portable isolation units using 3-d printing technology](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10429.md)
* [Rapid production and adoption of new mask technologies may lead to quality and safety issues](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10433.md)
* [Reuse of the mask filter without proper cleaning or replacement](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10434.md)
* [Rise of counterfeit products](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10435.md)
* [Risk of adverse effects from anti-sars-cov-2 coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10436.md)
* [Risk of ineffective anti-sars-cov-2 coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10437.md)
* [Risk of low viability period of sars-cov-2 on solids](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10493.md)
* [Risk of resistance development to anti-sars-cov-2 coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11270.md)
* [Safety concerns with 3d-printed ppe](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11407.md)
* [Safety concerns with alternative ventilator designs](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11413.md)
* [Safety concerns with reusable masks and shields due to lack of medical testing and airtightness](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11414.md)
* [Scalability and cost of graphene-based coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11415.md)
* [Sharing of temperature data with mobile app via bluetooth can lead to unauthorized access of sensitive health information.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11420.md)
* [Shortage of facemasks](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11421.md)
* [Shortage of key logistical equipment such as masks, face shields, gloves, and testing kits in hospitals](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11422.md)
* [Shortage of personal protective equipment ppe](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11423.md)
* [Shortage of supply chain for critical ppe](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11424.md)
* [Shortages of personal protective equipment ppe](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11429.md)
* [Skin irritation and discomfort from prolonged wear of sensors and wearables](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11432.md)
* [Spread of sars-cov-2 through contact with contaminated surfaces](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11434.md)
* [Supply chain disruption](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11438.md)
* [Supply chain disruptions](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11463.md)
* [Toxicity of nanomaterials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12502.md)
* [Traditional ieq monitoring protocol involving high-cost, invasive environmental sensors with limited spatial dimension and data storage.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12554.md)
* [Transmission of contagious diseases through physical contact with actuator technology.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12980.md)
* [Uncertainty regarding the effectiveness of copper coatings on 3d-printed surfaces in inactivating the covid-19 virus.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13131.md)
* [Use of coffee yarn and silver nanotechnology in the face mask](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13448.md)
* [Use of disinfectants containing phenolic agents](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13750.md)
* [Use of disposable face masks contributing to environmental pollution and waste.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14675.md)
* [Use of energy-inefficient appliances](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14676.md)
* [Use of improperly adhered surgical disposable masks leading to reduced protection from sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_16789.md)
* [Use of low-cost open-source hardware and software may result in lower quality and reliability of monitoring systems.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_16790.md)
* [Use of pulse oximeter sensors at non-standard locations or with inaccurate sensors can lead to false readings and misinterpretation of oxygen saturation levels.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17248.md)
* [Use of unproven materials for antiviral applications](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17498.md)
* [Variability of biocidal activity of graphene-based materials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17625.md)
* [Wearable devices may not accurately capture and report the wearer’s health status, leading to unreliable data.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17626.md)
* [Wearable devices may not be accurate, leading to incorrect temperature readings and potential misdiagnosis or improper treatment.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18068.md)
* [Worsening air quality leading to high demand for n95 masks.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19087.md)

## These stakeholders can be supported by the following general blueprint(s)

* [Implementing Disease Containment Scenarios and Supply Chain Adaptations](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_17.md)

## This Stakeholder belongs to this Stakeholder Group

* [Manufacturing and production sector](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_57.md)
* [Private sector](https://github.com/mm80843/T3.5/blob/pages/StakeholderGroup/PBN__StakeholderGroup_15.md)

## This Stakeholder belongs to this Stakeholder Subgroup

* [Manufacturing and industry](https://github.com/mm80843/T3.5/blob/pages/StakeholderSubgroup/PBN__StakeholderSubgroup_62.md)
* [Production staff](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1875.md)

## This Stakeholder can get these Benefits from mitigation measures

* [Improved supply chain efficiency](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_37.md)

## This stakeholders can act on the following general blueprint(s)

* [Implementing Biosecurity Measures and Technological Solutions to Counter Infectious Diseases](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_17.md)
* [Implementing Contagious Disease Containment Strategies](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_25.md)
* [Implementing Disease Containment Scenarios and Supply Chain Adaptations](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_42.md)

## Type of the stakeholder

* [At risk](https://github.com/mm80843/T3.5/blob/pages/Stakeholder_Type/PBN__Stakeholder_Type_0.md)
* [Beneficiary](https://github.com/mm80843/T3.5/blob/pages/Stakeholder_Type/PBN__Stakeholder_Type_2.md)
* [Risk owner](https://github.com/mm80843/T3.5/blob/pages/Stakeholder_Type/PBN__Stakeholder_Type_1.md)

